Dubbed the first “highless marijuana” strain by Reuters, Avidekel was created with the guidance of Dr. Raphael Mechoulam, the father of modern cannabis research. This unique Indica-dominant strain was bred for superior anti-inflammatory properties and is most likely the world’s most thoroughly researched strain of medical cannabis.
Avidekel is most often found in a 15:1 CBD:THC ratio, meaning there are 15 parts CBD to 1 part THC. Because of its high CBD (14-18%) and low THC (<1%) content, consumers should not feel any psychoactive effects, but often experience relief with long-term use.
This strain exhibits a terpene profile dominated by beta-myrcene and alpha-pinene that lend the flower an earthy, piney smell with notes of cherry. Beta-myrcene may help elevate energy levels while reducing inflammation, while alpha-pinene can improve airflow to the lungs, and provide a neurobiological boost that may prevent memory loss. These two terpenes combined offer natural antibacterial properties that some believe help to slow the spread of infection and cancer cells.
Avidekel is ideal for patients seeking relief without the psychoactive effects of THC.
Evidence from patient therapy and clinical trials suggests that Avidekel may relieve seizures, migraines, anxiety, inflammation, pain, autoimmune and gastrointestinal symptoms and to boost bone density and immunity,
In a recent observational study carried out on a large population of pediatric patients, Avidekel was found to be an effective and safe treatment for symptom relief in Autism. After using a CBD-rich cannabis oil derived from Avidekel over six months, 90.2% of patients reported improvement in symptoms including depression, restlessness, rage attacks, anxiety, seizures, agitation, digestive problems, trouble sleeping, and more. Another study found it to be effective in reducing inflammation and pain related to autoimmune diseases such as Multiple Sclerosis.
Avidekel has been included in the following Tikun studies:
Top High CBD Strain (2015, 2016)
WHAT TO READ NEXT